MACS GMP T Cell TransAct from Miltenyi Biotec

(1) Human induced-T-to-natural killer cells have potent anti-tumour activitiesBiomarker ResearchDecember 1, 2022Zhiwu Jiang, Le Qin, Yuou Tang, Rui Liao, Jingxuan Shi, Bingjia He, Shanglin Li, Diwei Zheng, Yuanbin Cui, Qiting Wu, et al.CliniMACS CD8 reagent (200–070-115, Miltenyi Biotec, Germany) and activated by MACS GMP T cell transaction (170–076-156, Miltenyi Biotec, Germany) for 72 h according the manufacture’s protocols. On day 4, T cells were electroporated

(2) Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical TrialFrontiers in ImmunologyMarch 20, 2020Maria Castella et al.respectively). Cells were immediately activated using TransACT GMP Grade (Miltenyi Biotec, Cat. N. 170076-156) and transduced 24h later using CAR19-containing lentivirus at MOI = 10. A cell culture wash was programmed 48

(3) Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMolecular Therapy - Methods & Clinical DevelopmentMarch 15, 2019Maria Castella, Anna Boronat, Raquel MartÃn-IbÃ¡Ã±ez, Vanina RodrÃguez, Guillermo SuÃ±Ã©, Miguel Caballero, Berta Marzal, Lorena PÃ©rez-Amill, Beatriz MartÃn-Antonio, Julio CastaÃ±o, et al.170-076-111 and 170-076-114, respectively). For T cell activation, TransACT GMP Grade (Miltenyi Biotec, 170-076-156) was used. Author Contributions M. Castella and A.B. designed and performed experiments, analyzed

Be the First to Write a Review!

MACS GMP T Cell TransAct from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (3)

Reviews

MACS GMP T Cell TransAct from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map